Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings has reported Long-Term Deferred Tax over the past 2 years, most recently at $426000.0 for Q1 2021.

Quarterly Long-Term Deferred Tax changed N/A to $426000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $426000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $40400.0 for FY2020, N/A changed from the prior year.
Long-Term Deferred Tax was $426000.0 for Q1 2021 at GeneDx Holdings, up from $40400.0 in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $426000.0 in Q1 2021 and troughed at $12000.0 in Q3 2020.